Ophthalmic compositions for treating ocular hypertension
US7279490B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2003 |
| Grant date | Oct 9, 2007 |
| Priority date | — |
| Expiry date | Mar 8, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to selective m1 muscarinic agonist, their use or a formulation thereof in the treatment of glaucoma and/or other conditions which are related to elevated intraocular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans. In addition, the present invention relates to the use of the compounds in the treatment of dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia, atrophic gastritis, and atony of gastrointestinal tract.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.